Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting (SBIRT)

This study has been completed.
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: February 17, 2010
Last updated: May 20, 2013
Last verified: May 2013
The goal of this research is to assess the impact of the "screening, brief intervention, and referral to treatment" (SBIRT) intervention strategy for harmful substance use among HIV-positive people.

Substance Use

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting

Resource links provided by NLM:

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • reduced substance use among HIV-positive people [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • technological innovation to improve the quality of medical care [ Time Frame: 6 months ]

Enrollment: 210
Study Start Date: July 2010
Study Completion Date: May 2013
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
clinician administered SBIRT

Detailed Description:

The specific aims of the study are:

  1. To assess the feasibility of conducting SBIRT using (1) a patient self-administered intervention embedded in a web-based Personal Health Record (PHR) compared to (2) a provider-administered SBIRT intervention guided by the Electronic Medical Record (EMR) during clinic appointments.
  2. To examine the acceptability of web-based PHRs to conduct and communicate SBIRT compared to EMR-activated SBIRT conducted by clinic staff, from the perspective of the patient and the provider.
  3. To assess the impact of SBIRT on risky drug and alcohol use in an HIV/AIDS population and subsequent effects on sexual risk behaviors and antiretroviral therapy (ART) adherence.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
primary care clinic patients

Inclusion Criteria:

  • 18 years of age
  • confirmed prior HIV+ serostatus
  • ability to provide informed consent to be a participant over a 6 month period
  • English or Spanish speaking

Exclusion Criteria:

Inability to answer questions with interviewer assistance. Not receiving primary care in clinic.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01300806

Sponsors and Collaborators
University of California, San Francisco
Principal Investigator: Carol Dawson Rose, PhD University of California, San Francisco
  More Information

Responsible Party: University of California, San Francisco Identifier: NCT01300806     History of Changes
Other Study ID Numbers: 09035355
Study First Received: February 17, 2010
Last Updated: May 20, 2013

Keywords provided by University of California, San Francisco:
harmful substance use processed this record on May 24, 2017